RE: The rationale for using hydroxycarbamide in the treatment of sickle cell disease

Simeon Pollack

doi:10.3324/haematol.2011.046409

RE: The rationale for using hydroxycarbamide in the treatment of sickle cell disease

Simeon Pollack

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	937
Number of pages	1
Journal	Haematologica
Volume	96
Issue number	6
DOIs	https://doi.org/10.3324/haematol.2011.046409
State	Published - Jun 2011

Keywords

N-3 fatty acids
Sickle cell anemia

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2011.046409

Cite this

@article{caa45a985cc64b59abb3a89d794966ec,

title = "RE: The rationale for using hydroxycarbamide in the treatment of sickle cell disease",

keywords = "N-3 fatty acids, Sickle cell anemia",

author = "Simeon Pollack",

year = "2011",

month = jun,

doi = "10.3324/haematol.2011.046409",

language = "English (US)",

volume = "96",

pages = "937",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "6",

}

TY - JOUR

T1 - RE

T2 - The rationale for using hydroxycarbamide in the treatment of sickle cell disease

AU - Pollack, Simeon

PY - 2011/6

Y1 - 2011/6

KW - N-3 fatty acids

KW - Sickle cell anemia

UR - https://www.scopus.com/pages/publications/80052930292

UR - https://www.scopus.com/pages/publications/80052930292#tab=citedBy

U2 - 10.3324/haematol.2011.046409

DO - 10.3324/haematol.2011.046409

M3 - Letter

C2 - 21632838

AN - SCOPUS:80052930292

SN - 0390-6078

VL - 96

SP - 937

JO - Haematologica

JF - Haematologica

IS - 6

ER -

RE: The rationale for using hydroxycarbamide in the treatment of sickle cell disease

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this